BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• 

  Collaboration

  JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy

  Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with insitro, Orbital and more are building the future.

  January 12, 2026

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  Policy

  At JPM26, Experts Try To Look Past the Most Favored Nation ‘Distraction’

  Former European Trade Commissioner Phil Hogan and former U.S. Senator Richard Burr, speaking on a panel at the J.P. Morgan Healthcare Conference, pushed to see a larger picture beyond the Trump administration’s year of chaos and confusion.

  January 12, 2026

   · 

  4 min read

   · 

  Dan Samorodnitsky
• Press Releases

  ACTG Launches IPACE-HIV to Study Frailty Intervention

  January 12, 2026

   · 

  3 min read
• Press Releases

  Continued Zenocutuzumab Treatment Beyond Progression Shows Benefit in Patients with NRG1+ Pancreatic Cancer and Cholangiocarcinoma: New Results from the eNRGy Trial Presented at ASCO GI

  January 12, 2026

   · 

  10 min read
• Press Releases

  Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

  January 12, 2026

   · 

  7 min read
• Press Releases

  Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

  January 12, 2026

   · 

  6 min read
• Press Releases

  City of Hope Appoints Veteran Life Sciences Leader Vanessa Almendro Navarro as Chief Commercialization Officer

  January 12, 2026

   · 

  4 min read
• Press Releases

  Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026

  January 12, 2026

   · 

  5 min read
• Press Releases

  SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39

  January 12, 2026

   · 

  3 min read
• Press Releases

  Chai Discovery Announces Collaboration with Eli Lilly and Company to Accelerate Biologics Discovery

  January 12, 2026

   · 

  2 min read